Novartis AG vs Tripadvisor Inc Common Stock — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Tripadvisor Inc Common Stock trades at $13.82 (market cap $1.68B). The key difference: Novartis AG is far larger — about 172.8× Tripadvisor Inc Common Stock's market cap, and Novartis AG pays a 3.17% dividend while Tripadvisor Inc Common Stock pays none. Which is the better fit depends on your goals.
| NVS | TRIP | |
|---|---|---|
Market Cap | $290.25B | $1.68B |
Sector | Health | Consumer Cyclical |
52-Week High | $168.62 | $19.14 |
52-Week Low | $113.50 | $9.24 |
Enterprise Value | $330.27B | $1.80B |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →